Medical oncology: IMP3 is a novel prognostic marker for colon cancer

Nature Reviews Clinical Oncology

Volumn 7, Issue 3, 2010, Pages 123-

  Hutchinson, Lisa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN LIKE GROWTH FACTOR II MESSENGER RNA BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; COLON CANCER; COLON MUCOSA; LASER CAPTURE MICRODISSECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77749252612     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2010.15     Document Type: Article

References (1)

1. Original article Li, D. et al. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Ann. Surg. Oncol. 16, 3499-3506 (2009)